&nbsp;

Jul 2023

Drug

aldesleukin

Other Name(s): Proleukin® (interleukin-2)

Quick Link(s):

Dec 1969

Drug

raltitrexed

Other Name(s): Tomudex®

Quick Link(s):

Dec 1969

Drug

riTUXimab

Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™

Quick Link(s):

Oct 2023

Drug

arsenic trioxide

Other Name(s): Trisenox®

Quick Link(s):

Oct 2023

Drug

romidepsin

Other Name(s): Istodax®

Quick Link(s):

Mar 2023

Drug

ramucirumab

Other Name(s): Cyramza®

Quick Link(s):

Mar 2023

Regimen

ALDE(Intralesional)

Cancer Type:

Skin,

Melanoma

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma

Drugs Used:

aldesleukin

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

AZCT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML),

Myelodysplastic Syndrome (MDS),

Myeloproliferative Neoplasms (MPNs)

Intent: Palliative

Funding:

New Drug Funding Program

Azacitidine - Intermediate-2 and high-risk myelodysplastic syndrome (MDS)

New Drug Funding Program

Azacitidine - Acute Myeloid Leukemia (AML)

New Drug Funding Program

Azacitidine - Acute Myeloid Leukemia (AML) Greater Than 30% Blasts

Drugs Used:

azaCITIDine

... Show more tags

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

AC-DOCE; AC-DOCE+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma

Drugs Used:

riTUXimab

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

AC-PACL(W); AC-PACL(W)+TRAS

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used: